Omitted stock option grant corrected for NHI (NYSE: NHI) SVP
Rhea-AI Filing Summary
NATIONAL HEALTH INVESTORS INC updated an insider ownership report for SVP, Legal Affairs Elizabeth Jackson Blankenship to reflect a previously omitted stock option grant. The amendment shows three tranches of stock options, each with an exercise price of $73.34 per share and expiring on March 3, 2030.
The options relate to underlying Common Stock in amounts of 8,333, 8,333 and 8,334 shares, with exercisability dates on March 3, 2025, March 3, 2026 and March 3, 2027, respectively. The footnote explains the grant was inadvertently omitted from the original Form 3 and is held directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Blankenship Elizabeth Jackson
Role
SVP, Legal Affairs
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) 2025 | -- | -- | -- |
| holding | Stock Option (Right to Buy) 2025 | -- | -- | -- |
| holding | Stock Option (Right to Buy) 2025 | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) 2025 — 25,000 shares (Direct)
Footnotes (1)
- F1. Reflects a stock option grant that was inadvertently omitted from the original Form 3.
Key Figures
Exercise price: $73.34 per share
Underlying shares tranche 1: 8,333 shares
Underlying shares tranche 2: 8,333 shares
+5 more
8 metrics
Exercise price
$73.34 per share
Stock Option (Right to Buy) 2025
Underlying shares tranche 1
8,333 shares
Common Stock underlying first option tranche
Underlying shares tranche 2
8,333 shares
Common Stock underlying second option tranche
Underlying shares tranche 3
8,334 shares
Common Stock underlying third option tranche
Option expiration date
March 3, 2030
All reported stock option tranches
First exercisability date
March 3, 2025
Stock Option (Right to Buy) 2025
Second exercisability date
March 3, 2026
Stock Option (Right to Buy) 2025
Third exercisability date
March 3, 2027
Stock Option (Right to Buy) 2025
Key Terms
Form 3/A, stock option grant, Stock Option (Right to Buy) 2025, underlying security, +1 more
5 terms
Form 3/A regulatory
"omitted from the original Form 3."
An amended Form 3 (Form 3/A) is a corrected or updated disclosure filed with regulators that revises an insider’s initial report of their ownership in a public company — typically for officers, directors or large shareholders. Investors use it like a corrected inventory list: it clarifies who owns how many shares and whether earlier reports had errors, helping assess insider confidence, possible conflicts and the accuracy of ownership records that can affect stock valuation and trust.
stock option grant financial
"Reflects a stock option grant that was inadvertently omitted"
Stock Option (Right to Buy) 2025 financial
"security_title": "Stock Option (Right to Buy) 2025""
underlying security financial
"underlying_security_title": "Common Stock""
exercise price financial
"conversion_or_exercise_price": "73.3400""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the amended Form 3/A for NHI disclose about Elizabeth Jackson Blankenship?
The amended Form 3/A updates Elizabeth Jackson Blankenship’s insider holdings to include a previously omitted stock option grant. It clarifies her direct right to acquire NHI Common Stock through options that were granted earlier but not shown on the original Form 3.
What is the exercise price and expiration date of the NHI stock options in this Form 3/A?
Each reported stock option has an exercise price of $73.34 per share and an expiration date of March 3, 2030. This means the insider may choose to buy NHI Common Stock at $73.34 per share any time before that expiration, subject to exercisability dates.
When do the NHI stock options reported for Elizabeth Jackson Blankenship become exercisable?
The amendment shows three exercisability dates: March 3, 2025, March 3, 2026 and March 3, 2027. Each date corresponds to a separate tranche of stock options, allowing staged potential exercises over three years before final expiration in 2030.
Does the NHI Form 3/A indicate a new transaction or simply correct prior reporting?
The Form 3/A indicates a correction to prior reporting, not a new option transaction. A footnote explains the stock option grant was previously made but inadvertently omitted from the original Form 3, so this amendment brings the insider ownership record up to date.